Study news - SYNTAX III Revolution


June 29, 2016

First patient included in SYNTAX III Revolution study

On June the 29th 2016, the first patient was included in the SYNTAX III Revolution study, in the University Hospital Brussels. Congratulations to the team of Dr. Sonck, prof. La Meir and Prof. De Mey! On to the next 222 patients!

May 17, 2016

SYNTAX III Revolution investigator meeting at EuroPCR congress

In the heart of Paris, at the Palais de Congresse, the first SYNTAX III Revolution Investigator Meeting took place during the EuroPCR conference. Scientific discussions based on a virtual case- and protocol outline presentation were followed by practical considerations on study infrastructure and flow. It was an interesting and interactive meeting, where the last remaining items for study start-up were discussed. We were excited to see the enthusiasm and involvement of all investigators! All parties are moving full speed ahead to obtain EC approval, and are looking forward to start this leading-edge study as soon as possible.

April 5, 2016

GE Healthcare, Heartflow and ECRI sign 'Agreement' for SYNTAX III Revolution study

GE Healthcare, Heartflow and ECRI have signed an 'Agreement' to initiate activities for the SYNTAX III Revolution study. All parties are very excited to enter into collaboration for this revolutionary new project. The objective of this study is to compare a Heart Team clinical decision making strategy either based solely on non-invasive CT angiography (GE RevolutionTM) with and without adjunction of HeartFlow FFRCT or based solely on conventional invasive angiography.